Monoclonal antibodies against N-Terminus proBNP
View Patent ↗Monoclonal antibodies having high affinity for N-terminus pro brain natriuretic peptide (NT-proBNP) are described. The monoclonal antibodies are prepared against a synthetic peptide having the Sequence ID No. 1. Specifically, the monoclonal antibodies described are produced from two hybridoma cell lines, 6G11-F11-D12 and 1C3-E11-R9, deposited with the American Type Culture Collection under Accession Numbers PTA-4844 and PTA-4845 respectively. The monoclonal antibody antibodies can be used as reagents in an immunoassay system to identify blood, serum or plasma levels of NT-proBNP. Such an immunoassay system can be used for diagnosing and quantifying congestive heart failure (CHF).
1. A hybridoma cell line 6G11-F11-D12, deposited with American Type Culture Collection under Accession Number PTA-4844.
2. A monoclonal antibody produced from hybridoma cell line 6G11-F11-D12, deposited with American Type Culture Collection under Accession Number PTA-4844.
3. A hybridoma cell line 1C3-E11-H9, deposited with American Type Culture Collection under Accession Number PTA-4845.
4. A monoclonal antibody produced from hybridoma cell line 1C3-E11-H9, deposited with American Type Culture Collection under Accession Number PTA-4845.